TRIO Completes Enrolment for Phase 2 Giredestrant Early Breast Cancer Trial Ahead of Schedule

NEXT STORY
AREV Expands Operations to Rochester New York Establishing Wholly Owned U.S. Subsidiary, AREV Life Sciences, Inc.
PREV STORY
Teleflex Announces Real-World Clinical Data Presentations of the UroLift® System at the 36th Annual European Association of Urology Congress
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Persbericht Biocartis Group NV: Biocartis kondigt nieuwe samenwerking aan met AstraZeneca om beschikbaarheid van Idylla™ EGFR biomarker testing bij longkankerpatiënten uit te breiden

author_avatar
NASDAQ Market News

CytomX Therapeutics to Announce First Quarter 2019 Financial Results

author_avatar
NASDAQ Market News

Vaccinex Presents Updated Interim Data from a Phase 1b/2 Study of Pepinemab (VX15/2503) in Combination with Avelumab (BAVENCIO®) in Non-Small Cell Lung Cancer in Podium and Poster Presentations at the Fifth International Cancer lmmunotherapy Conference in Paris, France

author_avatar
NASDAQ Market News